Iceland's export volume grows, value stagnates

21 May 2006

Iceland's statistical office has reported a significant increase in volume of pharmaceutical exports, although unit price falls have resulted in lower value growth.

Statistics Iceland confirmed that, for the first quarter of this year, the country exported 132 tonnes of drugs compared with 118 tonnes last year, an increase of 11.9%. In value terms, the increase was 3.0% year-on-year, with 1.32 billion kronur ($18.8 million) in the first quarter 2006 and 1.28 billion kronur for the equivalent period in 2005.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight